Repligen Corp (NASDAQ: RGEN) on Tuesday, plunged -5.92% from the previous trading day, before settling in for the closing price of $161.1. Within the past 52 weeks, RGEN’s price has moved between $102.96 and $182.52.
The company achieved an average annual earnings per share of 5.93%. With a float of $53.15 million, this company’s outstanding shares have now reached $56.25 million.
Repligen Corp (RGEN) Insider and Institutional Ownership
Observing investor behavior towards Medical Instruments & Supplies industry stocks is more important than anything else. The insider ownership of Repligen Corp is 5.52%, while institutional ownership is 98.28%. The most recent insider transaction that took place on Sep 10 ’25, was worth 3,508,389. In this transaction Director of this company sold 29,111 shares at a rate of $120.52, taking the stock ownership to the 100,743 shares. Before that another transaction happened on Sep 10 ’25, when Company’s Director proposed sale 29,111 for $120.52, making the entire transaction worth $3,508,378.
Repligen Corp (RGEN) Latest Financial update
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported 0.44 earnings per share (EPS) for the period topping the consensus outlook (set at 0.41) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.45 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 5.93% per share during the next fiscal year.
Repligen Corp (NASDAQ: RGEN) Trading Performance Indicators
Repligen Corp (RGEN) is currently performing well based on its current performance indicators. A quick ratio of 7.32 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 12.65. Likewise, its price to free cash flow for the trailing twelve months is 80.48.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.25, a number that is poised to hit 0.46 in the next quarter and is forecasted to reach 2.15 in one year’s time.
Technical Analysis of Repligen Corp (RGEN)
Repligen Corp (NASDAQ: RGEN) saw its 5-day average volume 1.34 million, a positive change from its year-to-date volume of 0.82 million. As of the previous 9 days, the stock’s Stochastic %D was 50.41%.
During the past 100 days, Repligen Corp’s (RGEN) raw stochastic average was set at 69.04%, which indicates a significant increase from 30.68% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 6.62 in the past 14 days, which was higher than the 5.00 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $133.91, while its 200-day Moving Average is $135.18. Nevertheless, the first resistance level for the watch stands at $161.88 in the near term. At $172.20, the stock is likely to face the second major resistance level. The third major resistance level sits at $177.77. If the price goes on to break the first support level at $145.99, it is likely to go to the next support level at $140.42. The third support level lies at $130.10 if the price breaches the second support level.
Repligen Corp (NASDAQ: RGEN) Key Stats
Market capitalization of the company is 8.53 billion based on 56,258K outstanding shares. Right now, sales total 634,440 K and income totals -25,510 K. The company made 182,370 K in profit during its latest quarter, and 14,870 K in sales during its previous quarter.
